15651287|t|[Biomarkers of Alzheimer's disease].
15651287|a|Recent researches of CSF biomarkers, such as combinations of tau, A beta40, A beta42, are now establishing clinical evidence. These specific biomarkers should be used in clinical practice. To detect incipient AD form MCI and very early AD, these CSF biomarkers are quite useful. Newly developing biomarkers, such as phosphorylated tau and plasma A beta, must be established by large scale prospective study and autopsy-correlations. Thus, the contribution of these biomarkers is desired for diagnosis and clinical practice for Alzheimer's disease.
15651287	15	34	Alzheimer's disease	Disease	MESH:D000544
15651287	98	101	tau	Gene	4137
15651287	113	121	A beta42	Gene	351
15651287	246	248	AD	Disease	MESH:D000544
15651287	254	257	MCI	Disease	
15651287	273	275	AD	Disease	MESH:D000544
15651287	368	371	tau	Gene	4137
15651287	383	389	A beta	Gene	351
15651287	564	583	Alzheimer's disease	Disease	MESH:D000544
15651287	Association	MESH:D000544	4137
15651287	Association	MESH:D000544	351

